Carbetapentane / phenylephrine / pyrilamine Pregnancy and Breastfeeding Warnings
Brand names: C-Tanna 12D, Tannate 12D S, Tannihist-12D, Tussi-12D, Tussi-12D S
Carbetapentane / phenylephrine / pyrilamine Pregnancy Warnings
Carbetapentane/phenylephrine/pyrilamine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Carbetapentane/phenylephrine/pyrilamine is only recommended for use during pregnancy when benefit outweighs risk.
Carbetapentane / phenylephrine / pyrilamine Breastfeeding Warnings
There are no data on the excretion of carbetapentane/phenylephrine/pyrilamine into human milk. The manufacturer recommends that due to the potential for adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
References for pregnancy information
- Product Information. Tussi-12D (carbetapentane/phenylephrine/pyrilamine). Meda AB. 2005.
- Product Information. Tussi-12D S (carbetapentane/phenylephrine/pyrilamine). Meda AB. 2005.
References for breastfeeding information
- Product Information. Tussi-12D (carbetapentane/phenylephrine/pyrilamine). Meda AB. 2005.
- Product Information. Tussi-12D S (carbetapentane/phenylephrine/pyrilamine). Meda AB. 2005.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.